PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
22-Aug-2024 Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project Cumulus Oncology
22-Aug-2024 Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor Adcendo ApS and Multitude Therapeutics Inc
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 osteolabs Publishes First Real-World Evidence Data from Close to 3,000 OsteoTest Patient Samples osteolabs
16-Aug-2024 CV6 Therapeutics Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168 CV6 Therapeutics
16-Aug-2024 A-Level students urged to consider pharmaceutical careers Association of the British Pharmaceutical Industry (ABPI)
14-Aug-2024 OrganaBio Manufactures First GMP Cryopreserved Leukopaks for Two New Biopharma Partners’ Allogeneic Cell Therapies OrganaBio
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
14-Aug-2024 SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer SpyBiotech
14-Aug-2024 Breakthrough heart MRI technique accurately predicts heart failure risk in general population The University of East Anglia (UEA)
14-Aug-2024 Cellomatics underpins continued US and European expansion with two business development hires Cellomatics Biosciences
14-Aug-2024 Santhera Closes Financings and Secures Funds to Reach Break-Even Expected in 2026 Santhera Pharmaceuticals
14-Aug-2024 New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease
14-Aug-2024 PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors PureTech Health plc
14-Aug-2024 NEJM publishes positive results for nipocalimab Phase 2 UNITY clinical study for early onset severe (EOS) haemolytic disease of the foetus and newborn (HDFN). Johnson & Johnson
14-Aug-2024 NICE recommends Yselty®▼ (linzagolix) for treating moderate to severe symptoms of uterine fibroids in adult women of reproductive age Theramex
14-Aug-2024 ViroCell Biologics completes oversubscribed financing ViroCell Biologics
14-Aug-2024 NHS requires compliance with BSI Kitemark™ to promote responsible antibiotic manufacturing BSI
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics
14-Aug-2024 Register now for Lab Innovations 2024 Lab Innovations